PIK3CA and neoplasm: The H3 K27M mutation was confirmed by NGS, which also identified three mutations in the tyrosine kinase domain of FGFR1 (amino acids 478–767) and a mutation in PIK3CA. Over the course of 23 months, the tumor has demonstrated no evidence of regrowth, and has remained unchanged in size.